Shared on10 Aug 25Fair value Increased 11%
The consensus analyst price target for Definitive Healthcare has increased as the company’s future P/E ratio jumped significantly despite a sharp decline in net profit margin, raising fair value from $4.10 to $4.37. What's in the News Provided Q3 2025 revenue guidance of $59.0–$60.0 million.